company
as of 2026-07-01National Alliance for Research on Schizophrenia and Depression
at a glance
41 trials sponsored · 42 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
42 assets
AripiprazoleRisperidoneZiprasidoneAcamprosateAtomoxetine (Strattera™)Brain Stimulation via Transcranial Magnetic StimulationCognitive RemediationCognitive Remediation TherapyCognitive Retraining (CRT)Cognitive TherapyCognitive trainingD-serineDexmedetomidineDivalproex Sodium Extended-Release TabletsDronabinolEstradiolFASTFolateFunctional magnetic resonance imagingGalantamineKetamineMecamylamineN-acetylcysteineOmega-3 capsulesOmega-3 fish oil capsules (including DHA)Paranoia-Focused Cognitive Behavioral Therapy (PFCBT)Social Skills TrainingStandard careTranscranial Magnetic Stimulation (TMS)Using Medications EffectivelyVareniclineadjunctive treatment with buspironearmodafinil (Nuvigil)ceftriaxonecomputer gamescreatinedosingglycineomega-3 PUFAsoxygenrepetitive Transcranial Magnetic Stimulationrosiglitazone
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Aripiprazole
drugsmall molecule
Risperidone
drugsmall molecule
Ziprasidone
drugsmall molecule
Acamprosate
drugsmall molecule
Atomoxetine (Strattera™)
drugsmall molecule
Cognitive Remediation
drugBEHAVIORAL
Cognitive Remediation Therapy
drugBEHAVIORAL